0001209191-20-009437.txt : 20200214
0001209191-20-009437.hdr.sgml : 20200214
20200213193822
ACCESSION NUMBER: 0001209191-20-009437
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200213
EFFECTIVENESS DATE: 20200214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-360594
FILM NUMBER: 20612955
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
D
1
primary_doc.xml
X0708
D
LIVE
0001175680
CytoDyn Inc.
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
360-980-8524
DELAWARE
RexRay Corporation
CYTODYN INC
REXRAY CORP
Corporation
true
Nader
Z
Pourhassan
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Executive Officer
Director
Craig
Eastwood
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Executive Officer
Jordan
G
Naydenov
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Director
Alan
P
Timmins
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Director
Scott
A
Kelly
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Director
David
F
Welch
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Director
Maura
Fleming
1111 Main Street, Suite 600
Vancouver
WA
WASHINGTON
98660
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2020-01-31
false
true
true
true
false
0
7570000
7570000
0
false
3
0
0
0
Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3.
true
CytoDyn Inc.
/s/ Craig Eastwood
Craig Eastwood
Chief Financial Officer
2020-02-12